E1A inhibits the proliferation of human cervical cancer cells (HeLa cells) by apoptosis induction through activation of HER-2/Neu/Caspase-3 pathway

Medical Oncology

Volumn 25, Issue 2, 2008, Pages 222-228

  Shen, Liangfang ^a   Zeng, Shan ^a   Chen, Jia ^a   Zhong, Meizuo ^a   Yang, Huixiang ^a   Yao, Ruojing ^a   Shen, Hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Cervical carcinoma; E1A; HeLa cells; HER 2 Neu

Indexed keywords

CASPASE 3; E1A PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL COUNT; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; FEMALE; GENE THERAPY; GENETICS; HELA CELL; PHYSIOLOGY; UTERINE CERVIX TUMOR;

ADENOVIRUS E1A PROTEINS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE THERAPY; HELA CELLS; HUMANS; RECEPTOR, ERBB-2; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 48049090986     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-9007-1     Document Type: Article

References (30)

1. Jemal A, Thomas A, Murray T, et al.Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. G Dreyer LC Snyman A Mouton 2005 Management of recurrent cervical cancer Best Pract Res Clin Obstet Gynaecol 19 631 44
3. SR Quist S Wang-Gohrke T Kohler 2004 Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status Cancer Gene Ther 11 547 54
4. SM. Frisch 1991 Antioncogenic effect of adenovirus E1A in human tumor cells Proc Natl Acad Sci U S A 88 9077 81
5. Z Li CP Day JY Yang 2004 Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53 Cancer Res 64 9080 5
6. H Chen MC. Hung 1997 Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene J Biol Chem 272 6101 4
7. A Sharma M Pratap VM Sawhney 1999 Frequent amplification of C-erbB2 (HER-2/Neu) oncogene in cervical carcinoma as detected by non-fluorescence in situ hybridization technique on paraffin sections Oncology 56 83 7
8. A Serrano-Olvera A Duenas-Gonzalez D Gallardo-Rincon 2006 Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer Cancer Treat Rev 32 180 90
9. A Chavez-Blanco V Perez-Sanchez A Gonzalez-Fierro 2004 HER2 expression in cervical cancer as a potential therapeutic target BMC Cancer 4 59
10. NT Ueno C Bartholomeusz W Xia 2002 Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene Cancer Res 62 6712 6
11. S Li MA Rizzo S Bhattacharya 1998 Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery Gene Ther 5 930 7
12. H Shen G Huang M Hadi 2003 Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol 285 G539 46
13. H Shen M Zhang GY Minuk 2002 Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation BMC Cell Biol 3 9
14. YJ Chun IC Park MJ Park 2002 Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3) FEBS Lett 519 195 200
15. GN Hortobagyi NT Ueno W Xia 2001 Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial J Clin Oncol 19 3422 33
16. S Madhusudan A Tamir N Bates 2004 A multicenter Phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene Clin Cancer Res 10 2986 96
17. Z Zhou RR Zhou H Guan 2003 E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model Mol Cancer Ther 2 1313 9
18. X Li YP Zhang HS Kim 2005 Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer Cancer Res 65 1941 51
19. NT Ueno C Bartholomeusz JL Herrmann 2000 E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway Clin Cancer Res 6 250 9
20. H Sakahira M Enari S. Nagata 1998 Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis Nature 391 96 9
21. M Shimizu A Deguchi JT Lim 2005 (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells Clin Cancer Res 11 2735 46
22. R Hou QL Zhou BX Wang 2004 Diosgenin induces apoptosis in HeLa cells via activation of caspase pathway Acta Pharmacol Sin 25 1077 82
23. YW Huang MD Li QL Wu 2002 [Expression and clinical significance of p53 and c-erbB2 in geriatric women with cervical carcinoma] Ai Zheng 21 297 300
24. JY Chang W Xia R Shao 1997 The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer Oncogene 14 561 8
25. CJ. Sherr 1998 Tumor surveillance via the ARF-p53 pathway Genes Dev 12 2984 91
26. Y Jiang HI Saavedra MP Holloway 2004 Aberrant regulation of survivin by the RB/E2F family of proteins J Biol Chem 279 40511 20
27. HG Wang Y Rikitake MC Carter 1993 Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth J Virol 67 476 88
28. JS Mymryk K Shire ST. Bayley 1994 Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block Oncogene 9 1187 93
29. SK Chiou E. White 1997 p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis J Virol 71 3515 25
30. Flinterman MB, Mymryk JS, Klanrit P, et al. p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene 2007. doi: 10.1038/sj.onc.1210497.